Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-04

Clinical Trial Update: Resveratrol in Knee Osteoarthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating resveratrol for knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resveratrol (resveratrol)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Knee Osteoarthritis | Phase 3 | Status: COMPLETED